Hsd:SD |
serum aspartate aminotransferase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood aspartate transaminase amount |
male |
84 days
| 5 |
156.2 |
U/l |
18.1 |
40.47 |
automated serum analysis |
|
0 |
106366 |
3025 |
Hsd:SD |
serum alkaline phosphatase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood alkaline phosphatase amount |
male |
84 days
| 5 |
74.6 |
U/l |
16.6 |
37.12 |
automated serum analysis |
|
0 |
106370 |
3025 |
Hsd:SD |
serum total protein level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood total protein amount |
male |
84 days
| 5 |
70.0 |
g/dl |
5.0 |
11.18 |
automated serum analysis |
|
0 |
106382 |
3025 |
Hsd:SD |
blood albumin level to blood globulin level ratio |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood albumin amount |
male |
84 days
| 5 |
1.8 |
null |
0.1 |
0.22 |
automated serum analysis |
|
0 |
106394 |
3025 |
Hsd:SD |
serum total cholesterol level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood cholesterol amount |
female |
84 days
| 5 |
106.8 |
mg/dl |
6.6 |
14.76 |
automated serum analysis |
|
0 |
106400 |
3025 |
Hsd:SD |
serum sodium level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood sodium amount |
female |
84 days
| 5 |
149.0 |
mmol/l |
2.2 |
4.92 |
automated serum analysis |
|
0 |
106420 |
3025 |
Hsd:SD |
serum potassium level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood potassium amount |
female |
84 days
| 5 |
8.1 |
mmol/l |
1.0 |
2.24 |
automated serum analysis |
|
0 |
106424 |
3025 |
Hsd:SD |
serum triglyceride level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood triglyceride amount |
female |
84 days
| 5 |
130.4 |
mg/dl |
35.4 |
79.16 |
automated serum analysis |
|
0 |
106404 |
3025 |
Hsd:SD |
serum total bilirubin level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood bilirubin amount |
male |
84 days
| 5 |
0.05 |
mg/dl |
0.0 |
0.0 |
automated serum analysis |
|
0 |
106374 |
3025 |
Hsd:SD |
serum globulin level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood globulin amount |
female |
84 days
| 5 |
2.2 |
g/dl |
0.2 |
0.45 |
automated serum analysis |
|
0 |
106392 |
3025 |
Hsd:SD |
serum urea nitrogen level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood urea nitrogen amount |
male |
84 days
| 5 |
22.4 |
mg/dl |
1.7 |
3.8 |
automated serum analysis |
|
0 |
106406 |
3025 |
Hsd:SD |
serum triglyceride level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood triglyceride amount |
male |
84 days
| 5 |
156.8 |
mg/dl |
12.9 |
28.85 |
automated serum analysis |
|
0 |
106402 |
3025 |
Hsd:SD |
serum chloride level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood chloride amount |
female |
84 days
| 5 |
100.4 |
mmol/l |
4.8 |
10.73 |
automated serum analysis |
|
0 |
106428 |
3025 |
Hsd:SD |
serum calcium level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood calcium amount |
female |
84 days
| 5 |
13.9 |
mg/dl |
0.7 |
1.57 |
automated serum analysis |
|
0 |
106432 |
3025 |
Hsd:SD |
serum alkaline phosphatase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood alkaline phosphatase amount |
female |
84 days
| 5 |
77.0 |
U/l |
8.2 |
18.34 |
automated serum analysis |
|
0 |
106372 |
3025 |
Hsd:SD |
serum albumin level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood albumin amount |
female |
84 days
| 5 |
4.5 |
g/dl |
0.2 |
0.45 |
automated serum analysis |
|
0 |
106388 |
3025 |
Hsd:SD |
serum creatinine level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood creatinine amount |
female |
84 days
| 5 |
0.34 |
mg/dl |
0.05 |
0.11 |
automated serum analysis |
|
0 |
106412 |
3025 |
Hsd:SD |
serum glucose level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood glucose amount |
male |
84 days
| 5 |
285.0 |
mg/dl |
47.3 |
105.77 |
automated serum analysis |
|
0 |
106414 |
3025 |
Hsd:SD |
serum potassium level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood potassium amount |
male |
84 days
| 5 |
7.9 |
mmol/l |
0.7 |
1.57 |
automated serum analysis |
|
0 |
106422 |
3025 |
Hsd:SD |
serum calcium level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood calcium amount |
male |
84 days
| 5 |
13.2 |
mg/dl |
0.7 |
1.57 |
automated serum analysis |
|
0 |
106430 |
3025 |
Hsd:SD |
serum total protein level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood total protein amount |
female |
84 days
| 5 |
67.0 |
g/dl |
3.0 |
6.71 |
automated serum analysis |
|
0 |
106384 |
3025 |
Hsd:SD |
blood albumin level to blood globulin level ratio |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood albumin amount |
female |
84 days
| 5 |
2.1 |
null |
0.1 |
0.22 |
automated serum analysis |
|
0 |
106396 |
3025 |
Hsd:SD |
serum alanine aminotransferase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood alanine transaminase amount |
female |
84 days
| 5 |
65.0 |
U/l |
5.4 |
12.07 |
automated serum analysis |
|
0 |
106364 |
3025 |
Hsd:SD |
serum albumin level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood albumin amount |
male |
84 days
| 5 |
4.5 |
g/dl |
0.3 |
0.67 |
automated serum analysis |
|
0 |
106386 |
3025 |
Hsd:SD |
serum total cholesterol level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood cholesterol amount |
male |
84 days
| 5 |
113.8 |
mg/dl |
8.5 |
19.01 |
automated serum analysis |
|
0 |
106398 |
3025 |
Hsd:SD |
serum creatinine level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood creatinine amount |
male |
84 days
| 5 |
0.3 |
mg/dl |
0.0 |
0.0 |
automated serum analysis |
|
0 |
106410 |
3025 |
Hsd:SD |
serum sodium level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood sodium amount |
male |
84 days
| 5 |
149.4 |
mmol/l |
1.5 |
3.35 |
automated serum analysis |
|
0 |
106418 |
3025 |
Hsd:SD |
serum alanine aminotransferase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood alanine transaminase amount |
male |
84 days
| 5 |
56.6 |
U/l |
14.9 |
33.32 |
automated serum analysis |
|
0 |
106362 |
3025 |
Hsd:SD |
serum aspartate aminotransferase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood aspartate transaminase amount |
female |
84 days
| 5 |
134.2 |
U/l |
13.2 |
29.52 |
automated serum analysis |
|
0 |
106368 |
3025 |
Hsd:SD |
serum total bilirubin level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood bilirubin amount |
female |
84 days
| 5 |
0.05 |
mg/dl |
0.0 |
0.0 |
automated serum analysis |
|
0 |
106376 |
3025 |
Hsd:SD |
serum globulin level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood globulin amount |
male |
84 days
| 5 |
2.5 |
g/dl |
0.2 |
0.45 |
automated serum analysis |
|
0 |
106390 |
3025 |
Hsd:SD |
serum urea nitrogen level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood urea nitrogen amount |
female |
84 days
| 5 |
24.6 |
mg/dl |
1.5 |
3.35 |
automated serum analysis |
|
0 |
106408 |
3025 |
Hsd:SD |
serum chloride level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood chloride amount |
male |
84 days
| 5 |
100.2 |
mmol/l |
1.6 |
3.58 |
automated serum analysis |
|
0 |
106426 |
3025 |
Hsd:SD |
serum phosphate level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood phosphate amount |
female |
84 days
| 5 |
12.6 |
mg/dl |
3.0 |
6.71 |
automated serum analysis |
|
0 |
106436 |
3025 |
Hsd:SD |
serum phosphate level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood phosphate amount |
male |
84 days
| 5 |
12.3 |
mg/dl |
3.2 |
7.16 |
automated serum analysis |
|
0 |
106434 |
3025 |
Hsd:SD |
serum glucose level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood glucose amount |
female |
84 days
| 5 |
311.2 |
mg/dl |
107.9 |
241.27 |
automated serum analysis |
|
0 |
106416 |
3025 |